Mechanisms and Effects of Steroids on Cells and Immune Function

Steroid hormones reshape immune function by entering cells, binding to receptors that act as gene switches, and altering the expression of hundreds of proteins involved in inflammation and defense. Glucocorticoids, the class most widely prescribed for immune-related conditions, suppress inflammatory signaling, redirect immune cell traffic, and push certain white blood cells toward programmed death. But the picture is not simply “steroids turn off immunity.” Different steroid types, doses, and durations produce strikingly different cellular outcomes, and the body’s own cortisol uses many of these same pathways every day to fine-tune how and when the immune system responds to threats.

How Steroids Enter Cells and Alter Gene Expression

The classic mechanism starts with a steroid molecule crossing the cell membrane, which it can do easily because steroids are fat-soluble. Once inside the cytoplasm, a glucocorticoid binds to the glucocorticoid receptor (GR), a protein that normally sits in an inactive state, tethered to a cluster of chaperone molecules. When the hormone locks in, the receptor changes shape, sheds parts of that chaperone complex, and exposes signals that shuttle it into the nucleus.¹ Once inside, the receptor pairs up with a partner copy and binds to specific stretches of DNA called glucocorticoid response elements. This binding can switch target genes on (transactivation) or off (transrepression), depending on the gene and the DNA sequence involved. Negative response elements, for example, recruit proteins that silence gene activity rather than boost it.¹ Androgen receptors follow a broadly similar playbook: a steroid binds a receptor, the receptor enters the nucleus, and gene expression shifts. The details differ in which genes are targeted and which co-regulator proteins are recruited, which is why testosterone and cortisol produce such different downstream effects on the body.²

This genomic pathway takes time. Changing gene expression, producing new proteins, and seeing cellular effects typically requires at least thirty minutes and often hours. Yet some steroid effects happen in seconds. Researchers have identified a separate, rapid mode of action in which steroid receptors sitting at or near the cell membrane trigger signaling cascades normally associated with growth factors. These “non-genomic” effects can activate enzymes and second messengers within moments of hormone exposure.³ The two pathways are not independent. Genomic and non-genomic signals cross-talk, with rapid membrane events influencing which genes are ultimately turned on or off in the nucleus.⁴ This dual-speed system gives steroids an unusually broad toolkit for reshaping cell behavior.

Suppressing Inflammation From the Inside

The most therapeutically important effect of glucocorticoids is their ability to shut down inflammatory gene programs. A central target is NF-κB, a transcription factor that activates dozens of genes responsible for producing inflammatory signaling molecules. Glucocorticoids block NF-κB by boosting production of its natural inhibitor, a protein called IκBα, which traps NF-κB in the cytoplasm and prevents it from reaching the nucleus.⁵ Because NF-κB drives the production of so many pro-inflammatory molecules in response to infection and tissue damage, disabling it accounts for a large share of why glucocorticoids calm inflammation so effectively.

The activated glucocorticoid receptor can also directly bind to and inactivate other pro-inflammatory transcription factors like AP-1, adding another layer of suppression.⁶ The net result is a broad dampening of inflammatory cytokine production, reduced immune cell activation, and a shift in the signaling environment from one that promotes attack to one that promotes resolution and tissue repair.

Effects on Specific Immune Cell Types

Glucocorticoids do not hit all immune cells equally. Their effects are selective and sometimes paradoxical, strengthening certain defensive functions while dismantling others.

T Cells

T cells are among the most sensitive targets. Glucocorticoids can drive T cells into apoptosis, and this ability to trigger lymphocyte death is one reason synthetic glucocorticoids are used in treating blood cancers and autoimmune diseases.⁷ Even at lower, physiological levels, cortisol reshapes T cell populations. Naive T cells, the ones waiting to encounter a new pathogen for the first time, are driven out of the bloodstream during the daytime cortisol peak, likely redirected to the bone marrow through cortisol-induced increases in a homing receptor called CXCR4. Meanwhile, experienced effector T cells are mobilized into circulation by catecholamines like epinephrine.⁸ The practical upshot is that your body’s own stress hormones configure the immune system to favor immediate, already-trained defense during waking hours while saving the more elaborate process of mounting new immune responses for nighttime rest periods.

Long-term glucocorticoid exposure also leaves epigenetic marks on T cells. A clinical study of patients with prolonged glucocorticoid exposure found persistent changes in DNA methylation patterns that disrupted a key growth-signaling pathway affecting CD4+ T cell biology, meaning the effects lingered even after hormone levels normalized.⁹

Macrophages

Macrophages come in different functional flavors. The M1 type is pro-inflammatory: it produces reactive oxygen species and cytokines that fight pathogens. The M2 type is anti-inflammatory: it promotes tissue repair and dampens immune attack. Glucocorticoids consistently push macrophages from the M1 state toward M2. In autoimmune uveitis (eye inflammation), glucocorticoid treatment inhibited pro-inflammatory markers and promoted anti-inflammatory ones, encouraging M1-to-M2 transition.¹⁰ Similar shifts have been documented in immune thrombocytopenia, where high-dose dexamethasone decreased M1 markers and increased M2 markers, and the rebalanced macrophages suppressed T cell proliferation and expanded regulatory T cells.¹¹ In childhood lupus nephritis, initial steroid treatment similarly flipped macrophages from M1 to M2.¹² This polarization shift is therapeutic when the goal is to quiet an autoimmune attack, but it also explains part of why prolonged steroid use weakens antimicrobial defense.

Dendritic Cells

Dendritic cells serve as the immune system’s scouts, capturing foreign material and presenting it to T cells to initiate an adaptive response. Glucocorticoids impair dendritic cells at multiple stages. When dendritic cells develop in the presence of glucocorticoids, they become a functionally distinct population incapable of triggering an effective immune response, with reduced production of key activating cytokines and diminished ability to stimulate T cells, even though certain pathogen-sensing receptors were actually increased on their surface.¹³ Dexamethasone also blocked dendritic cells from picking up and processing foreign material, though it did not prevent them from presenting material they had already processed.¹⁴ Even the body’s own cortisol (corticosterone in rodents) at normal physiological concentrations compromised dendritic cell maturation and sharply reduced their ability to prime naive CD8+ T cells, offering a cellular explanation for why chronic stress suppresses new immune responses.¹⁵

B Cells and Granulocytes

Corticosteroids affect B cells in a graded way depending on what stage the B cell is in. Early activation and proliferation are strongly suppressed, but once a B cell has already committed to producing antibodies, steroids have little inhibitory effect and may even enhance immunoglobulin secretion.¹⁶ This explains why steroid therapy can blunt new antibody responses while leaving existing antibody-producing cells relatively intact.

Granulocytes, the most abundant white blood cells, respond to glucocorticoids with a seemingly paradoxical rise in blood counts. The mechanism is physical: glucocorticoids reorganize the actin skeleton inside these cells, making them softer and less sticky. Softer granulocytes detach from blood vessel walls where they normally linger (a process called demargination), flooding back into the circulating bloodstream. This biomechanical effect, not increased production, is what drives the clinical finding of elevated white cell counts after a dose of steroids.¹⁷

The Daily Rhythm of Immune Readiness

Your body produces cortisol in a predictable daily pattern, peaking in the early morning and falling to a low point around midnight. This rhythm is not just about waking you up. Research shows that the daily cortisol wave actively directs immune cell movement, guiding specific populations to particular organs and tissues at the times when they are most likely to be needed.¹⁸ As noted earlier, cortisol drives naive T cells out of circulation during the day while effector cells increase, a configuration that favors rapid defense during active hours and saves new immune learning for sleep. This stress-hormone system is extraordinarily old. The same hormonal axis that controls cortisol release in humans has been maintained by natural selection across mammals, birds, fish, reptiles, and amphibians for hundreds of millions of years, suggesting it provides a fundamental survival advantage.¹⁹²⁰

The evolutionary tradeoff, however, is real. Short bursts of cortisol help the body survive acute threats. Sustained high levels, whether from chronic stress, disease, or medication, tip the balance toward immunosuppression and tissue damage.¹⁹

Gut Barrier and Microbiome Effects

The intestinal lining is a single layer of cells sealed together by tight junctions, and glucocorticoids play a dual role here. Under inflammatory conditions, glucocorticoids protect the gut barrier by suppressing an enzyme called MLCK that inflammatory signals use to pry open tight junctions. The activated glucocorticoid receptor binds directly to the MLCK gene promoter and silences it, preventing the barrier from breaking down.²¹ Glucocorticoids also adjust the types of sealing proteins in tight junctions, reducing pore-forming proteins and increasing barrier-strengthening ones.²²

But context matters. When glucocorticoids are chronically elevated, especially alongside other insults like alcohol, the same receptor system can promote barrier dysfunction, bacterial leakage into the bloodstream, and systemic inflammation. Studies in mice showed that corticosterone worsened alcohol-induced gut permeability, and this effect depended on the glucocorticoid receptor in intestinal lining cells.²³

Glucocorticoids also reshape the gut microbiome. A randomized controlled trial in healthy young men found that oral glucocorticoids shifted bacterial composition, increasing certain species linked to insulin resistance and immunosuppression markers.²⁴ In patients receiving high-dose glucocorticoids for Graves’ ophthalmopathy, gut microbial diversity changed significantly, the production of short-chain fatty acids dropped, and the altered microbial profile correlated with metabolic side effects like high blood sugar and elevated blood pressure.²⁵

Infection Risk and Opportunistic Pathogens

The combined suppression of T cells, macrophage function, and dendritic cell maturation creates a predictable vulnerability: people on corticosteroids face a higher risk of infection. Beyond common bacterial infections, the risk of opportunistic pathogens rises. Conditions like Pneumocystis pneumonia, herpes zoster (shingles), and tuberculosis are well-documented complications of corticosteroid therapy.²⁶ In a national cohort of systemic lupus patients, the rate of opportunistic infections was roughly 136 times higher among those using steroids compared to non-users. The risk of mycobacterial infection was about 11 times higher, and the risk of herpes zoster was about 44 times higher, even after accounting for other immunosuppressive drugs and underlying health conditions.²⁷

Beyond infection, glucocorticoid-induced muscle wasting is another major side effect driven by cellular mechanisms. Glucocorticoids ramp up protein breakdown in muscle, primarily through the ubiquitin-proteasome system, while simultaneously blunting protein synthesis. They increase expression of genes that tag muscle proteins for destruction and shift the balance of growth factors: the muscle-building signal IGF-I goes down while myostatin, a catabolic signal, goes up.²⁸

When Glucocorticoids Stop Working

Not everyone responds to glucocorticoid therapy, and resistance is a significant clinical problem. Several molecular reasons have been identified. Certain inflammatory cytokines can activate signaling pathways that counteract the receptor’s suppressive effects. In some patients, an enzyme called HDAC2, which the glucocorticoid receptor needs to silence inflammatory genes, is reduced in activity due to oxidative stress, effectively disabling the receptor’s ability to shut down inflammation.²⁹ Other sources of resistance include increased activity of the drug efflux pump P-glycoprotein, which actively pumps steroids out of cells before they can bind their receptors, lowering the effective intracellular dose.³⁰ Genetic variations in the receptor gene itself, in chaperone proteins, and in drug-transporting enzymes all contribute to why the same dose of prednisone can work beautifully for one patient and fail completely for another.³⁰

Anabolic-Androgenic Steroids and Immunity

Anabolic-androgenic steroids (AAS) are a completely different family from glucocorticoids, and their immune effects follow different patterns. A study of strength-trained athletes using AAS found that T cell subset numbers did not differ between users and non-users, but natural killer cell activity was significantly higher in the steroid-using group. Interestingly, serum IgA, an antibody important for mucosal immunity, was significantly lower in AAS users.³¹ Animal studies add nuance: initial exposure to anabolic steroids produced immunosuppression, but by ten days in, some compounds had flipped to immunostimulation. The stimulatory effect disappeared after castration, suggesting it was linked to changes in the body’s own testosterone production rather than a direct effect of the drug.³²

More recently, proteomic analysis of long-term AAS users found 11 proteins involved in inflammation and tissue remodeling that were expressed at different levels compared to non-users. Six of these were elevated, including interleukin-8 and hepatocyte growth factor, and the signaling pathways most affected were ones tied to inflammatory processes and cardiac fibrosis.³³ Where glucocorticoids broadly suppress inflammation, long-term AAS use appears to promote a low-grade inflammatory state, particularly one that remodels heart and connective tissue. The two steroid classes, despite sharing the basic steroid molecular skeleton, push the immune system in largely opposite directions.

Glucocorticoid Effects on the Microbiome Across Species

The impact of glucocorticoids on gut bacteria is not limited to humans. In Chinook salmon treated with cortisol, gut microbial diversity increased, while synthetic dexamethasone reduced diversity compared to untreated fish.³⁴ The fact that natural and synthetic glucocorticoids can push the microbiome in different directions, even within the same species, underscores how much the specific compound, dose, and duration matter. It also suggests that microbiome disruption is not a uniquely human side effect of steroid therapy but a conserved biological consequence across vertebrates, much like the stress-hormone system itself. Whether in a lupus patient on prednisone, a healthy volunteer swallowing dexamethasone pills in a clinical trial, or a salmon in a research tank, glucocorticoids reshape the microbial communities that the host depends on for metabolic and immune support.